The Europe Cardiac Catheters & Guidewires Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).
Cardiac catheterization often takes place in a medical facility or surgery clinic. A team of medical experts, which may include other doctors, technicians, and other healthcare providers, will support the doctor. An intravenous (IV) line will be inserted into the arm or hand by a nurse prior to beginning the heart catheterization operation. Patients will get fluids and medications through the IV line before, during, and after the treatment.
Cardiac catheterization is frequently used to identify and treat specific heart diseases. It entails inserting a slender, flexible tube into the heart through a blood artery. With the aid of the catheter, the doctor can operate on the patient's heart to perform diagnostic tests and other treatments. Usually, the femoral artery or the groyne is used for this surgery.
The femoral artery has taken over as the preferred method for cardiac catheterization because it is bigger and provides a direct path to the heart. But recently, there has been a sharp rise in the use of the radial artery for cardiac catheterization procedures. In comparison to the femoral route, the radial artery approach is less likely to cause bleeding and problems, making it safer for patients.
The healthcare system in Sweden is also among the greatest and most advanced in the world. The 10 million people living there are in very good health overall. The adoption of cardiac catheters & guidewires is anticipated to increase in the region due to a strong healthcare system and expand the market for medical equipment. As a result, the regional market's expansion for cardiac catheters & guidewires over the forecast period.
The Germany market dominated the Europe Cardiac Catheters & Guidewires Market by Country in 2021; thereby, achieving a market value of $1,186.7 million by 2028. The UK market is exhibiting a CAGR of 6.2% during (2022 - 2028). Additionally, The France market would experience a CAGR of 7.9% during (2022 - 2028).
Based on Product, the market is segmented into Cardiac Catheters and Cardiac Guidewires. Based on Cardiac Catheters Type, the market is segmented into Electrophysiology Catheters, PTCA Balloons Catheters, IVUS Catheters, PTA Balloons Catheters, Guide Extension Catheters and Others. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cardiac Catheters & Guidewires Market will Hit $19 Billion by 2028, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Getinge AB, Cardinal Health, Inc., Biotronik SE & Co. KG, Medtronic PLC, Nipro Corporation, Merit Medical Systems, Inc., Teleflex, Inc. and B. Braun Melsungen AG
By Product
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
